Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: E.J. Neitz Jr who wrote (17096)	8/19/2004 5:39:52 PM
From: Edscharp	Read Replies (1) \| Respond to of 17367

E.J. Fred was exactly right a few posts ago. Betting on Xoma is a bet on Raptiva. They have nothing else in their pipeline that can affect share price in the intermediate term. But, I wouldn't compare their bounce backs from the past with their current situation. Hopes for bpi products (IMO) are smashed and Xoma management has sunk into a black hole of incredibility. Furthermore, modest growth of Raptiva will be insufficient to turn any heads. They really need monster sales and quickly., I wouldn't call it a good bet, but it could be a good return if I'm wrong.